Novo Nordisk Aktie
46,55
EUR
-1,56
EUR
-3,23
%
45,99
EUR
-3,04
EUR
-6,20
%
Werbung
Novo Nordisk Aktie Analyse
08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.21 | Novo Nordisk overweight | Barclays Capital | |
04.02.21 | Novo Nordisk Neutral | Credit Suisse Group | |
04.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.21 | Novo Nordisk Outperform | Bernstein Research | |
03.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.21 | Novo Nordisk Neutral | UBS AG | |
Werbung
|
|||
03.02.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
26.01.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.01.21 | Novo Nordisk Neutral | Credit Suisse Group | |
20.01.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.01.21 | Novo Nordisk buy | Deutsche Bank AG | |
04.01.21 | Novo Nordisk kaufen | JP Morgan Chase & Co. | |
17.12.20 | Novo Nordisk Neutral | UBS AG | |
01.12.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.11.20 | Novo Nordisk Neutral | UBS AG | |
09.11.20 | Novo Nordisk Underweight | Morgan Stanley | |
06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.11.20 | Novo Nordisk Neutral | UBS AG | |
02.11.20 | Novo Nordisk Outperform | Credit Suisse Group | |
30.10.20 | Novo Nordisk kaufen | Bernstein Research | |
30.10.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
30.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
30.10.20 | Novo Nordisk Neutral | UBS AG | |
30.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
09.10.20 | Novo Nordisk Neutral | UBS AG | |
09.10.20 | Novo Nordisk Verkaufen | DZ BANK | |
09.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.09.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
25.09.20 | Novo Nordisk Neutral | UBS AG | |
18.08.20 | Novo Nordisk Neutral | UBS AG | |
14.08.20 | Novo Nordisk Hold | Kepler Cheuvreux | |
11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
07.08.20 | Novo Nordisk Outperform | Credit Suisse Group |
Werbung
Werbung